Management of Severe Malaria Cases
DOI:
https://doi.org/10.53089/medula.v13i1.584Keywords:
malaria, management, complicationAbstract
Malaria is a disease caused by the infection of Plasmodium parasite. Severe Malaria is accompanied by complications such as cerebral Malaria, seizures, acute kidney failure, hemodynamic shock, and so on. intravenous artesunate is the first-line treatment for severe Malaria caused by all Plasmodium species. Early RRT therapy is necessary to manage acute renal failure, also careful fluid resuscitation is important to prevent lethal pulmonary edema. Delayed-onset hemolysis following Artesunate administration necessitate hemoglobin checks and post-treatment monitoring. ACT treatment is the first line treatment after complications have subsided, followed by primaquine administration to treat relapse cases. G6PD testing is required before primaquine administration to prevent hemolysis.
References
World Health Organization. Malaria Key Facts. Geneva: World Health Organization; 2021.
Kotepui M, Kotepui KU, Milanez GDJ, Masangkay FR. Plasmodium spp. mixed infection leading to severe Malaria: A systematic review and meta-analysis. Scientific Reports 2021;10(1):1-12.
World Health Organization. World Health Organization Guidelines for the treatment of Malaria. Edisi ke-3. Geneva: World Health Organization; 2015.
Plewes K, Leopold SJ, Kingston HWF, Dondorp AM. Malaria: What’s New in the Management of Malaria?. Infectious Disease Clinics 2019;33(1):39-60.
Esu EB, Effa EE, Opie ON, Meremikwu MM. Artemether for severe Malaria. Cochrane Database Syst Rev. 2019;6(6):CD010678.
World Health Organization. Severe Malaria. Trop Med Int Health 2014;19(Suppl 1):7–131.
Maude RJ, Hoque G, Hasan MU, Sayeed A, Akter S, Samad R, dkk. Timing of enteral feeding in cerebral Malaria in resource-poor settings: a randomized trial. PloS one 2011;6(11):e27273.
Mohanty S, Mishra SK, Patnaik R, Dutt AK, Pradhan S, Das B, dkk. Brain swelling and mannitol therapy in adult cerebral Malaria: a randomized trial. Clinical infectious diseases 2011;53(4):349-355.
Gwer SA, Idro RI, Fegan G, Chengo EM, Mpoya A, Kivaya E, dkk. Fosphenytoin for seizure prevention in childhood coma in Africa: a randomized clinical trial. Journal of critical care 2013;28(6):1086-1092.
Aung NM, Kaung M, Kyi TT, Kyaw MP, Min M, Htet ZW, dkk. The safety of a conservative fluid replacement strategy in adults hospitalised with Malaria. PLoS One 2015;10(11):e0143062.
Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, dkk. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney international supplements 2012;2(1):1-138.
William T, Menon J, Rajahram G, Chan L, Ma G, Donaldson S, dkk. Severe Plasmodium knowlesi Malaria in a tertiary care hospital, Sabah, Malaysia. Emerging infectious diseases 2011;17(7):1248.
Conroy AL, Hawkes M, Elphinstone RE, Morgan C, Hermann L, Barker KR, dkk. Acute kidney injury is common in pediatric severe Malaria and is associated with increased mortality. Open forum infectious diseases 2016;3:1-9.
Plewes K, Royakkers AA, Hanson J, Hasan MMU, Alam S, Ghose A, dkk. Correlation of biomarkers for parasite burden and immune activation with acute kidney injury in severe falciparum Malaria. Malaria Journal 2014;13(1):1-10.
Plewes K, Kingston HW, Ghose A, Maude RJ, Herdman MT, Leopold SJ, dkk. Cell-free hemoglobin mediated oxidative stress is associated with acute kidney injury and renal replacement therapy in severe falciparum Malaria: an observational study. BMC infectious diseases 2017;17(1):1-12.
Barber BE, Grigg MJ, Piera KA, William T, Cooper DJ, Plewes K, dkk. Intravascular haemolysis in severe Plasmodium knowlesi Malaria: association with endothelial activation, microvascular dysfunction, and acute kidney injury. Emerging microbes & infections 2018;7(1):1-10.
Hanson JP, Lam SW, Mohanty S, Alam S, Pattnaik R, Mahanta KC. Fluid resuscitation of adults with severe falciparum Malaria: effects on acid-base status, renal function, and extravascular lung water. Critical care medicine 2013;41(4):972-981.
Phu NH, Hanson J, Bethell D, Mai NTH, Chau TTH, Chuong LV, dkk. A retrospective analysis of the haemodynamic and metabolic effects of fluid resuscitation in Vietnamese adults with severe falciparum Malaria. PLoS One 2011;6(10):e25523.
Mishra OP, Gupta AK, Pooniya V, Prasad R, Tiwary NK, Schaefer F. Peritoneal dialysis in children with acute kidney injury: a developing country experience. Peritoneal dialysis international 2012;32(4):431-436.
Asinobi AO, Ademola AD, Alao MA. Haemodialysis for paediatric acute kidney injury in a low resource setting: experience from a tertiary hospital in South West Nigeria. Clinical Kidney Journal 2016;9(1):63-68.
Hanson J, Hasan MMU, Royakkers AA, Alam S, Charunwatthana P, Maude RJ, dkk. Laboratory prediction of the requirement for renal replacement in acute falciparum Malaria. Malaria journal 2011;10(1):1-9.
Plewes K, Kingston HW, Ghose A, Wattanakul T, Hassan MMU, Haider MS, dkk. Acetaminophen as a renoprotective adjunctive treatment in patients with severe and moderately severe falciparum Malaria: a randomized, controlled, open-label trial. Clinical Infectious Diseases 2018;67(7):991-999.
Chan XHS, Win YN, Mawer LJ, Tan JY, Brugada J, White NJ, dkk. Risk of sudden unexplained death after use of dihydroartemisinin–piperaquine for Malaria: a systematic review and Bayesian meta-analysis. The Lancet Infectious Diseases 2018;18(8):913-923.
Jauréguiberry S, Ndour PA, Roussel C, Ader F, Safeukui I, Nguyen M, dkk. Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins. Blood, The Journal of the American Society of Hematology 2014;124(2):167-175.
Ndour PA, Larréché S, Mouri O, Argy N, Gay F, Roussel C, dkk. Measuring the Plasmodium falciparum HRP2 protein in blood from artesunate-treated Malaria patients predicts post-artesunate delayed hemolysis. Science translational medicine2017;9(397):eaaf9377.
Nayyar GM, Breman JG, Newton PN, Herrington J. Poor-quality antiMalarial drugs in southeast Asia and sub-Saharan Africa. The Lancet infectious diseases 2012;12(6):488-496.
Barber BE, Grigg MJ, William T, Yeo TW, Anstey NM. The treatment of Plasmodium knowlesi Malaria. Trends in parasitology 2017;33(3):242-253.
Grigg MJ, William T, Barber BE, Rajahram GS, Menon J, Schimann E, dkk. Artemether-lumefantrine versus chloroquine for the treatment of uncomplicated Plasmodium knowlesi Malaria: an open-label randomized controlled trial CAN KNOW. Clinical Infectious Diseases 2018;66(2):229-236.
Grigg MJ, William T, Menon J, Dhanaraj P, Barber BE, Wilkes CS, dkk. Artesunate–mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi Malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial. The Lancet infectious diseases 2016;16(2):180-188.
Galappaththy GN, Tharyan P, Kirubakaran R. Primaquine for preventing relapse in people with Plasmodium vivax Malaria treated with chloroquine. Cochrane Database Syst Rev 2013;(10):CD004389.
Chu CS, Bancone G, Moore KA, Win HH, Thitipanawan N, Po C, dkk. Haemolysis in G6PD heterozygous females treated with primaquine for Plasmodium vivax Malaria: a nested cohort in a trial of radical curative regimens. PLoS medicine 2017;14(2):e1002224.
Watson J, Taylor WR, Bancone G, Chu CS, Jittamala P, White NJ. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax Malaria. PLoS neglected tropical diseases 2018;12(4):e0006440.
World Health Organization Global Malaria Programme. Single dose primaquine as a gametocytocide in Plasmodium falciparum Malaria. Geneva: World Health Organization; 2012.
Kouakou YI, Tod M, Leboucher G, Lavoignat, A., Bonnot, G., Bienvenu, A. L., & Picot, S. Systematic review of artesunate pharmacokinetics: implication for treatment of resistant Malaria. International Journal of Infectious Diseases 2019;89:30-44.
Bruneel F, Raffetin A, Corne P, Llitjos JF, Mourvillier B, Argaud L, dkk. Management of severe imported Malaria in adults. Médecine et Maladies Infectieuses 2020;50(2):213-225.
Vandermosten L, Pham TT, Knoops S, De Geest C, Lays N, Van der Molen K, dkk. Adrenal hormones mediate disease tolerance in Malaria. Nature communications 2018;9(1):1-18.
Igiraneza G, Ndayishimiye B, Nkeshimana M, Dusabejambo V, Ogbuagu O. 2018. Clinical profile and outcome of patients with acute kidney injury requiring hemodialysis. BioMed research international; 2018.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
